Literature DB >> 16918479

Induction of transplantation tolerance via regulatory T cells.

Manuela Battaglia1, Maria Grazia Roncarolo.   

Abstract

In the last two decades, graft survival has been greatly improved by the introduction of efficient immunosuppressive drugs. On the other hand, late graft loss caused by chronic rejection together with the side effects of long-term immunosuppression, remain major obstacles for successful transplantation. Operational tolerance, which is defined by the lack of acute and chronic rejection and indefinite graft survival with normal graft function in the absence of chronic immunosuppression, represents an attractive alternative. Several approaches have been explored to achieve transplantational tolerance, which is considered the "Holy Grail" of transplantation, including induction of central tolerance by establishing mixed chimerism through hematopoietic stem cell transplantation or induction of peripheral tolerance through modulation of allogeneic immune responses. Graft-specific alloreactive T cells, which largely mediate graft rejection, can be silenced through different mechanisms, including deletion, which may occur within the thymus or in the lymphoid organs; anergy, in which alloreactive T cells cannot adequately respond following restimulation with the specific antigen; and suppression, which may be mediated by direct interactions with regulatory T cells (Tregs) or by soluble factors produced by Tregs. This review attempts to summarize the most novel and successful strategies to achieve operational tolerance via induction of Tregs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16918479     DOI: 10.2174/187152806778256052

Source DB:  PubMed          Journal:  Inflamm Allergy Drug Targets        ISSN: 1871-5281


  6 in total

Review 1.  Regulatory T Cells in Post-stroke Immune Homeostasis.

Authors:  Arthur Liesz; Christoph Kleinschnitz
Journal:  Transl Stroke Res       Date:  2016-03-31       Impact factor: 6.829

2.  Idd13 is involved in determining immunoregulatory DN T-cell number in NOD mice.

Authors:  V Dugas; A Liston; E E Hillhouse; R Collin; G Chabot-Roy; A-N Pelletier; C Beauchamp; K Hardy; S Lesage
Journal:  Genes Immun       Date:  2014-01-16       Impact factor: 2.676

Review 3.  Functional role of regulatory lymphocytes in stroke: facts and controversies.

Authors:  Arthur Liesz; Xiaoming Hu; Christoph Kleinschnitz; Halina Offner
Journal:  Stroke       Date:  2015-03-19       Impact factor: 7.914

Review 4.  Immunotherapy following hematopoietic stem cell transplantation: potential for synergistic effects.

Authors:  Myriam N Bouchlaka; Doug Redelman; William J Murphy
Journal:  Immunotherapy       Date:  2010-05       Impact factor: 4.196

Review 5.  Manipulating the immune system for anti-tumor responses and transplant tolerance via mixed hematopoietic chimerism.

Authors:  Carrie Gibbons; Megan Sykes
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

6.  In vivo imaging of T cell delivery to tumors after adoptive transfer therapy.

Authors:  Mikael J Pittet; Jan Grimm; Cedric R Berger; Takahiko Tamura; Gregory Wojtkiewicz; Matthias Nahrendorf; Pedro Romero; Filip K Swirski; Ralph Weissleder
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-18       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.